INmune Bio, Inc. (INMB)
2.36
+0.12
(+5.36%)
USD |
NASDAQ |
Sep 02, 16:00
2.36
0.00 (0.00%)
After-Hours: 18:41
INmune Bio 1 Year Total Returns (Daily) : 10.34% for Sept. 1, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 01, 2026 | 10.34% |
| August 31, 2026 | 13.30% |
| August 28, 2026 | 11.48% |
| August 27, 2026 | 17.36% |
| August 26, 2026 | 13.19% |
| August 25, 2026 | 8.48% |
| August 24, 2026 | -2.07% |
| August 21, 2026 | -1.28% |
| August 20, 2026 | -8.47% |
| August 19, 2026 | -7.08% |
| August 18, 2026 | -16.60% |
| August 17, 2026 | -15.81% |
| August 14, 2026 | -11.43% |
| August 13, 2026 | -18.75% |
| August 12, 2026 | -15.70% |
| August 11, 2026 | -13.33% |
| August 10, 2026 | -17.19% |
| August 07, 2026 | -25.27% |
| August 06, 2026 | -30.80% |
| August 05, 2026 | -29.37% |
| August 04, 2026 | -33.10% |
| August 03, 2026 | -27.73% |
| July 31, 2026 | -35.90% |
| July 30, 2026 | -33.96% |
| July 29, 2026 | -46.52% |
| Date | Value |
|---|---|
| July 28, 2026 | -41.24% |
| July 27, 2026 | -36.16% |
| July 24, 2026 | -41.73% |
| July 23, 2026 | -39.86% |
| July 22, 2026 | -23.33% |
| July 21, 2026 | -17.23% |
| July 20, 2026 | -17.77% |
| July 17, 2026 | -15.18% |
| July 16, 2026 | -11.54% |
| July 15, 2026 | 0.00% |
| July 14, 2026 | -4.72% |
| July 13, 2026 | -19.48% |
| July 10, 2026 | -13.00% |
| July 09, 2026 | -24.15% |
| July 08, 2026 | -25.22% |
| July 07, 2026 | -24.35% |
| July 06, 2026 | -34.19% |
| July 02, 2026 | -27.97% |
| July 01, 2026 | -19.62% |
| June 30, 2026 | -29.44% |
| June 29, 2026 | -69.61% |
| June 26, 2026 | -77.39% |
| June 25, 2026 | -79.78% |
| June 24, 2026 | -79.58% |
| June 23, 2026 | -77.17% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 275.6% |
| Oncolytics Biotech, Inc. | -19.23% |
| Sangamo Therapeutics, Inc. | -68.46% |
| Sarepta Therapeutics, Inc. | 17.20% |
| Anixa Biosciences, Inc. | 9.70% |